107 related articles for article (PubMed ID: 11965378)
1. Benzimidazole-based fXa inhibitors with improved thrombin and trypsin selectivity.
Shaw KJ; Guilford WJ; Griedel BD; Sakata S; Trinh L; Wu S; Xu W; Zhao Z; Morrissey MM
Bioorg Med Chem Lett; 2002 May; 12(9):1311-4. PubMed ID: 11965378
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of aminophenol-based factor Xa inhibitors.
Wu S; Guilford WJ; Chou YL; Griedel BD; Liang A; Sakata S; Shaw KJ; Trinh L; Xu W; Zhao Z; Morrissey MM
Bioorg Med Chem Lett; 2002 May; 12(9):1307-10. PubMed ID: 11965377
[TBL] [Abstract][Full Text] [Related]
3. Similarity study of serine proteases inhibitors.
Perekhodtsev GD
Mol Divers; 2006 Feb; 10(1):81-3. PubMed ID: 16404529
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and in vitro biological activity of benzimidazole based factor Xa inhibitors.
Zhao Z; Arnaiz DO; Griedel B; Sakata S; Dallas JL; Whitlow M; Trinh L; Post J; Liang A; Morrissey MM; Shaw KJ
Bioorg Med Chem Lett; 2000 May; 10(9):963-6. PubMed ID: 10853669
[TBL] [Abstract][Full Text] [Related]
5. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and activity of a novel series of factor Xa inhibitors: optimization of arylamidine groups.
Phillips G; Guilford WJ; Buckman BO; Davey DD; Eagen KA; Koovakkat S; Liang A; McCarrick M; Mohan R; Ng HP; Pinkerton M; Subramanyam B; Ho E; Trinh L; Whitlow M; Wu S; Xu W; Morrissey MM
J Med Chem; 2002 Jun; 45(12):2484-93. PubMed ID: 12036356
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin.
Stubbs MT; Huber R; Bode W
FEBS Lett; 1995 Nov; 375(1-2):103-7. PubMed ID: 7498454
[TBL] [Abstract][Full Text] [Related]
8. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
9. 1,2-Dibenzamidobenzene inhibitors of human factor Xa.
Herron DK; Goodson T; Wiley MR; Weir LC; Kyle JA; Yee YK; Tebbe AL; Tinsley JM; Mendel D; Masters JJ; Franciskovich JB; Sawyer JS; Beight DW; Ratz AM; Milot G; Hall SE; Klimkowski VJ; Wikel JH; Eastwood BJ; Towner RD; Gifford-Moore DS; Craft TJ; Smith GF
J Med Chem; 2000 Mar; 43(5):859-72. PubMed ID: 10715153
[TBL] [Abstract][Full Text] [Related]
10. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
Zhou Y; Johnson ME
J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa.
Böhm M; St rzebecher J; Klebe G
J Med Chem; 1999 Feb; 42(3):458-77. PubMed ID: 9986717
[TBL] [Abstract][Full Text] [Related]
12. The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position.
Baettig U; Brown L; Brundish D; Dell C; Furzer A; Garman S; Janus D; Kane PD; Smith G; Walker CV; Cockcroft X; Ambler J; Mitchelson A; Talbot MD; Tweed M; Wills N
Bioorg Med Chem Lett; 2000 Jul; 10(14):1563-6. PubMed ID: 10915051
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of potent and selective factor Xa inhibitors: benzimidazole derivatives with the side chain oriented to the prime site of factor Xa.
Ueno H; Katoh S; Yokota K; Hoshi J; Hayashi M; Uchida I; Aisaka K; Hase Y; Cho H
Bioorg Med Chem Lett; 2004 Aug; 14(16):4281-6. PubMed ID: 15261287
[TBL] [Abstract][Full Text] [Related]
14. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors.
Guilford WJ; Shaw KJ; Dallas JL; Koovakkat S; Lee W; Liang A; Light DR; McCarrick MA; Whitlow M; Ye B; Morrissey MM
J Med Chem; 1999 Dec; 42(26):5415-25. PubMed ID: 10639283
[TBL] [Abstract][Full Text] [Related]
16. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
Wang G; Goyal N; Hopkinson B
Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
[TBL] [Abstract][Full Text] [Related]
17. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets.
Murcia M; Morreale A; Ortiz AR
J Med Chem; 2006 Oct; 49(21):6241-53. PubMed ID: 17034130
[TBL] [Abstract][Full Text] [Related]
18. Approaches to selective peptidic inhibitors of factor Xa.
Bromfield KM; Quinsey NS; Duggan PJ; Pike RN
Chem Biol Drug Des; 2006 Jul; 68(1):11-9. PubMed ID: 16923021
[TBL] [Abstract][Full Text] [Related]
19. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs.
Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O
Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897
[TBL] [Abstract][Full Text] [Related]
20. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
